30-09-2026 19:39 via nytimes.com

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Read more »

Health news



Scientists Warn of Another Unseen Risk From Fire: Ozone
Dying Patients Are Inundated by Misinformation. My Dad Was One of Them.
F.D.A. Classifies Salad Dressing Recall to Highest Health Risk
F.D.A. Found Cyclospora During Taylor Farms Inspection in Mexico
Scientists Untangle the Biology of an ‘Undruggable’ Cancer Gene
How Did Christa Pike Survive Two Lethal Injections of Pentobarbital?
Why Did the Tennessee Execution Fail?
Cornell’s Jane Doe Said She Was Given Ketamine. Here’s How the Drug Works.
What Role Did Ketamine Play in Cornell’s Alleged Rape Case?
The Most Disturbing 2000s Reality Show Doesn’t Seem So Crazy Anymore
Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy
New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
A.I. Is ‘Better Informed’ Than Doctors, Kennedy Tells Industry-Backed MAHA Summit
V.A. Institutes New Consent Requirements for Some Psychiatric Drugs
Desktop versie